EA
Review #1, NDA 20-358 |
Page 6 |
|
b. Controls
(Air, Liquid Effluent, Solid): |
|
See
Attachments 1 and 2 . |
|
The
controls exercised to prevent emission into the environment are described for
both drug substance
manufacture and formulation of drug product. |
|
On
page 6 off-site disposal is indicated.
The disposal locations should be identified and appropriate permits/license numbers
given. |
|
DEFICIENT. |
|
|
|
c. Compliance
with Federal, State and Local Emission Requirements: |
|
A
list of applicable regulations and laws as well as a statement of compliance
is included. |
|
Adequate. |
|
|
|
d. Effect
of Approval on Compliance with Current Emissions Requirements: |
|
It
is stated that air emissions, solid waste, or liquid waste resulting from the
action will not have an
adverse impact on compliance. |
|
Adequate. |
|
|
|
e. Estimated
Expected Emitted Concentration/Quantities: |
|
The
quantities of materials generated by production of 1 kg of drug substance are
given in confidential Appendix
B. All materials are removed by
incineration or wastewater pretreatment and
are not released. |
|
The
Maximum Expected Emitted Concentration (MEEC) for the use of the drug product
was calculated in confidential
Appendix B for the production volume of drug substance predicted for year four. |
|
The
maximum concentration of drug substance in the receiving water bodies that
would result from loss of a
days production (at each facility) into the production facility effluent was
also calculated. |
Back a Page
Next Page
Back to Wellbutrin SRŪ NDA Index Page
Back to Main
Index